Načítá se...
Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery
[Image: see text] Tuberculosis (TB) is the leading cause of mortality globally resulting from an infectious disease, killing almost 1.6 million people annually and accounting for approximately 30% of deaths attributed to antimicrobial resistance (AMR). This despite the widespread administration of a...
Uloženo v:
| Vydáno v: | Acc Chem Res |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Chemical
Society
2019
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6704484/ https://ncbi.nlm.nih.gov/pubmed/31361123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.accounts.9b00275 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|